Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  € $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth

Enquire | Email | Print

ISBN: GBIME0034MR
Published Date: Jul, 2011
Format: PDF
 
 
Select pricing :
Change Currency: € EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents
“Neurology Devices Market to 2017- High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth” provides key data, information and analysis on the global neurology devices market. The report provides market landscape, competitive landscape and market trends information on five neurology devices market categories – CSF management, neurosurgical products, neurostimulation devices, interventional neurology, and neurological diagnostic equipment. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and a detailed analysis of the pipeline products in each category. The report also reviews details about important merger and acquisition deals that have taken place in the neurology devices market during the past four years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope
  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Market size and company share data for five neurology devices market categories – CSF management, neurosurgical products, neurostimulation devices, interventional neurology, and neurological diagnostic equipment.
  • Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010 has been given for all categories.
  • Qualitative analysis of key market trends, market drivers, and restraints by each category within the endoscopy devices market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading technologies.
  • Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG and Cadwell Laboratories, Inc.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments that are driving the neurology devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • What’s the next being thing in the neurology devices market landscape? – Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global neurology devices market and the factors shaping it.

1 Table Of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Executive Summary 13
2.1 Global Neurology Devices Market is Forecast to Reach $7.2 Billion by 2017 13
2.2 Medtronic was the Leading Company in the Global Neurology Devices Market in 2010 14
2.3 The US was the Biggest Market for Neurology Devices in 2010 16
2.4 Neurostimulation Devices to Continue to be the Largest Category in the Global Neurology Device Market in 2010 17
3 Introduction 18
3.1 GBI Research Guidance 18
4 Global Neurology Devices Market Characterization 20
4.1 Global Neurology Devices Market, Revenue ($m), 2003–2010 20
4.2 Global Neurology Devices Market, Revenue Forecast ($m), 2010–2017 21
4.3 Global Neurology Devices Market, Key Trends 23
4.3.1 Neurostimulation Devices Segment Holds Significant Potential for Venture Capitalists 23
4.3.1.1 Imthera Medial Raises an Additional $0.4m in Venture Financing Round 24
4.3.1.2 MindFrame Secures $3.6m in Financing Round 24
4.3.2 Innovative Therapies to be a Mainstay in the Neurology Devices Market 24
4.3.3 Robotic Neurosurgery is Improving Accuracy at a Microscopic Level 25
4.3.4 Increasing Demand for Minimally Invasive Surgery is Positively Impacting the Interventional Neurology Market 26
4.4 Global Neurology Devices Market, Market Dynamics 27
4.4.1 Market Drivers 27
4.4.1.1 Multiple Indication Potential of Neurology Devices Will Drive Market Growth 27
4.4.1.2 Extensive Marketing Strategies Followed by Neurology Devices Companies will help to Increase Market Share 28
4.4.1.3 Improved Accuracy and Visualization in the Operating Room will Increase Surgeon Adoption Rates for Neurology Devices 28
4.4.2 Market Restraints 29
4.4.2.1 Reduction in Medicare Payments for Neurosurgeons to Affect Patients’ Access to Care Limiting Neurology Devices Market Growth 29
4.4.2.2 High Market Entry Barriers and Government Regulations Restrict Entry for New Players Limiting Market Growth 30
4.4.2.3 High Cost of Devices Acts as a Barrier for Neurology Devices Market Growth 30
4.5 Global Neurology Devices Market, Key Company Share (%), 2010 31
5 Global Neurology Devices Market: Category Analysis and Forecasts 34
5.1 Neurology Devices 34
5.2 CSF Management 35
5.2.1 CSF Management Market, Global, Revenue ($m), 2003–2010 35
5.2.2 CSF Management Market, Global, Revenue Forecast ($m), 2010–2017 37
5.2.3 CSF Management: Market Dynamics 38
5.2.4 Market Drivers 39
5.2.4.1 Increased Awareness of Neurological Disorders and Advanced Products will Propel CSF Management Market Growth 39
5.2.4.2 Increase in Number of Hydrocephalus Cases to Drive the Market in the Future 40
5.2.5 Market Restraints 40
5.2.5.1 Complications Associated with Hydrocephalus Shunting to Impact Market Growth 40
5.2.5.2 Lack of Specialized Training for Neurology Procedures among Surgeons to Limit Treatment Options, thereby Reducing CSF Management Market Growth 41
5.2.6 CSF Management Market, Global, Company Share (%), 2010 41
5.3 Neurosurgical Products 43
5.3.1 Neurosurgical Products Market, Global, Revenue ($m), 2003–2010 44
5.3.2 Neurosurgical Products Market, Global, Revenue Forecast ($m), 2010–2017 45
5.3.3 Neurosurgical Products Market Dynamics 47
5.3.4 Market Drivers 47
5.3.4.1 Growing Demand for Minimally Invasive Procedures to Drive Growth in the Neurosurgical Products Market 47
5.3.4.2 Neuroendoscope Market is Expected to Witness Healthy Growth in the Future Owing to Increased Demand from Pediatric Neurosurgery 48
5.3.5 Market Restraints 49
5.3.5.1 Complications and Technical Difficulties in Performing the Procedure and Advent of Ventricular Shunts is Slowing the Neurosurgical Products Market Growth 49
5.3.6 Neurosurgical Products Market, Global, Company Share (%), 2010 49
5.4 Neurostimulation Devices 51
5.4.1 Neurostimulation Devices Market, Global, Revenue ($m), 2003–2010 52
5.4.2 Neurostimulation Devices Market, Global, Revenue Forecasts ($m), 2010–2017 53
5.4.3 Neurostimulation Devices Market Dynamics 55
5.4.4 Market Drivers 55
5.4.4.1 Neurostimulation Devices Offers Multi-Indication Potential to Treat Neurological Disorders Giving a Boost to Market Growth 56
5.4.4.2 High Prevalence and Incidence of Neurological Disorders to Drive Market Growth in the Future 57
5.4.4.3 Robust Pipeline in Neurostimulation Devices is Expected to Bring New Products and Drive the Market Growth 57
5.4.4.4 Neurostimulation Devices a more Effective Mode of Treatment for Neurological Disorders than Drugs 59
5.4.4.5 Better Outcomes of Neurostimulation Devices Leading to an Increase in Neurosurgeon Adoption Rates 59
5.4.4.6 Technological Advancements in the Treatment of Parkinson’s Disease and the Growing Demand for Alternative Therapies Enhancing Prospects in the Neurostimulation Device Market 60
5.4.4.7 Clinical Data Proving the Efficacy of Neurostimulation Therapy for Chronic Neuropathic Leg and Back Pain Favoring Market Growth 61
5.4.5 Market Restraints 61
5.4.5.1 High Cost of Treatment and Lack of Awareness Among the Patient Population about Alternative Treatment Options of Pain is a Major Restraining Factor for Market Growth 61
5.4.5.2 Lack of Skilled Neurosurgeons in Emerging Countries such as India, China and Brazil Reducing Prescription Rates 62
5.4.6 Neurostimulation Device Market, Global, Company Shares (%), 2010 62
5.5 Interventional Neurology 64
5.5.1 Interventional Neurology Market, Global, Revenue ($m), 2003–2010 65
5.5.2 Interventional Neurology Market, Global, Revenue Forecasts ($m), 2010–2017 67
5.5.3 Interventional Neurology: Market Dynamics 69
5.5.4 Market Drivers 70
5.5.4.1 Increase in Prevalence of Neurovascular Diseased Population to Drive the Interventional Neurology Market 70
5.5.4.2 Increased Safety and Effectiveness Due to Technological Advancements in Embolic System for Treating Cerebral Aneurysms Has Reduced Recurrence and Retreatment Rates 71
5.5.5 Market Restraints 71
5.5.5.1 Shortage of Neurosurgeons Trained to use Aneurysm Prevention Devices and Advanced Stroke Limits the Availability of Treatment Options 71
5.5.6 Interventional Neurology Market, Global, Company Shares (%), 2010 71
5.6 Neurological Diagnostic Equipment 73
5.6.1 Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2003–2010 73
5.6.2 Neurological Diagnostic Equipment Market, Global, Revenue Forecasts ($m), 2010–2017 75
5.6.3 Neurological Diagnostic Equipment: Market Dynamics 77
5.6.4 Market Drivers 77
5.6.4.1 Advancements in Electroencephalography (EEG) Equipment Technology will Drive Future Growth in the Neurological Diagnostic Equipment Market 78
5.6.4.2 Rising Number of Physicians’ Offices Leading to Additional Sale of EEG and EMG Monitoring Devices 78
5.6.4.3 Rising Incidence of Neurological Disorders Resulting in Significant Growth of the Neurological Diagnostic Equipment Market 78
5.6.5 Market Restraints 79
5.6.5.1 Complications Related to the Usage of ICP Monitoring Devices has Limited the Market Growth of Neurological Diagnostic Equipment 79
5.6.5.2 Healthcare Reforms and Cost Containment Measures by Hospitals to Reduce Demand for Neurological Diagnostic Equipment 80
5.6.6 Neurological Diagnostic Equipment Market, Global, Company Shares (%), 2010 80
6 Global Neurology Devices Market: Country Analysis and Forecasts 83
6.1 Neurology Devices Market: Cross Country Analysis 83
6.2 Revenue Forecasts, By Country, 2003-2017 84
6.2.1 Neurology Devices Market, US, Revenue ($m), 2003–2010 84
6.2.2 Neurology Devices Market, US, Revenue ($m), 2010–2017 86
6.2.3 Neurology Devices Market, Canada, Revenue ($m), 2003–2010 88
6.2.4 Neurology Devices Market, Canada, Revenue ($m), 2010–2017 90
6.2.5 Neurology Devices Market, UK, Revenue ($m), 2003–2010 92
6.2.6 Neurology Devices Market, UK, Revenue ($m), 2010–2017 94
6.2.7 Neurology Devices Market, Germany, Revenue ($m), 2003–2010 95
6.2.8 Neurology Devices Market, Germany, Revenue ($m), 2010–2017 97
6.2.9 Neurology Devices Market, France, Revenue ($m), 2003–2010 99
6.2.10 Neurology Devices Market, France, Revenue ($m), 2010–2017 101
6.2.11 Neurology Devices Market, Italy, Revenue ($m), 2003–2010 102
6.2.12 Neurology Devices Market, Italy, Revenue ($m), 2010–2017 104
6.2.13 Neurology Devices Market, Spain, Revenue ($m), 2003–2010 106
6.2.14 Neurology Devices Market, Spain, Revenue ($m), 2010–2017 107
6.2.15 Neurology Devices Market, Japan, Revenue ($m), 2003–2010 109
6.2.16 Neurology Devices Market, Japan, Revenue ($m), 2010–2017 111
6.2.17 Neurology Devices Market, China, Revenue ($m), 2003–2010 113
6.2.18 Neurology Devices Market, China, Revenue ($m), 2010–2017 115
6.2.19 Neurology Devices Market, India, Revenue ($m), 2003–2010 116
6.2.20 Neurology Devices Market, India, Revenue ($m), 2010–2017 118
6.2.21 Neurology Devices Market, Australia, Revenue ($m), 2003–2010 119
6.2.22 Neurology Devices Market, Australia, Revenue ($m), 2010–2017 121
6.2.23 Neurology Devices Market, Brazil, Revenue ($m), 2003–2010 122
6.2.24 Neurology Devices Market, Brazil, Revenue ($m), 2010–2017 124
7 Global Neurology Devices Market: Competitive Assessment 126
7.1 Neurology Devices Market Opportunities and Risk Evaluation 126
7.2 Medtronic, Inc. 129
7.2.1 Business Overview 130
7.2.2 Key Products 130
7.3 Boston Scientific Corporation 133
7.3.1 Business Overview 133
7.3.2 Key Products 133
7.4 St. Jude Medical, Inc 135
7.4.1 Business Overview 136
7.4.2 Key Products 136
7.5 Integra LifeSciences Holdings Corporation 137
7.5.1 Business Overview 138
7.5.2 Key Products 138
7.6 B. Braun Melsungen AG 141
7.6.1 Business Overview 142
7.7 Cadwell Laboratories, Inc. 143
7.7.1 Business Overview 143
7.7.2 Key Products 144
8 Global Neurology Devices Market: Product Pipeline Analysis 147
8.1 Neurology Devices: Pipeline Products Summary 147
8.2 Neurostimulation Devices 148
8.2.1 Neurostimulation Devices: List of Pipeline Products 148
8.2.2 Neurostimulation Devices: Profiles of Key Pipeline Products 153
8.2.2.1 Vagus Nerve Stimulators 153
8.2.2.2 Deep Brain Stimulators 154
8.2.2.3 Spinal Cord Stimulators 155
8.2.2.4 Sacral Nerve Stimulators 155
8.2.2.5 Other Neurostimulation Devices 156
8.3 Interventional Neurology 156
8.3.1 Interventional Neurology: List of Pipeline Products 156
8.3.2 Interventional Neurology: Profiles of Key Pipeline Products 158
8.3.2.1 Embolic Systems 158
8.3.2.2 Navigational Systems 159
8.3.2.3 Other Interventional Neurology Devices 159
8.4 Neurological Diagnostic Equipment 160
8.4.1 Neurological Diagnostic Equipment: List of Pipeline Products 160
8.4.2 Neurological Diagnostic Equipment: Profiles of Key Pipeline Products 162
8.5 Neurosurgical Products 163
8.5.1 Neurosurgical Products: List of Pipeline Products 163
8.5.2 Neurosurgical Products: Profiles of Key Pipeline Products 164
8.6 CSF Management 165
8.6.1 CSF Management: List of Pipeline Products 165
8.6.2 CSF Management: Profiles of Key Pipeline Products 165
9 Global Neurology Device Market: Consolidation Landscape 167
9.1 Deals by Count, 2007-2010 167
9.2 Key Deals in 2007-2010 170
9.2.1 Johnson & Johnson Completes Acquisition of Micrus Endovascular 170
9.2.1.1 Deal Rationale 170
9.2.1.2 Company Overview 171
9.2.2 Covidien Completes Acquisition Of ev3 for $2.6 Billion 171
9.2.2.1 Deal Rationale 172
9.2.2.2 Company Overview 172
9.2.3 Medtronic Acquired NDI Medical 172
9.2.3.1 Deal Rationale 172
9.2.3.2 Company Overview 173
10 Appendix 174
10.1 Definitions 174
10.1.1 Neurology Devices 174
10.1.2 CSF Management 174
10.1.2.1 Dura Substitutes 174
10.1.2.2 Hydrocephalus Shunts 174
10.1.3 Interventional Neurology 174
10.1.3.1 Aneurysm Clips 174
10.1.3.2 Embolic Systems 174
10.1.3.3 Navigational Systems 175
10.1.3.4 Neurovascular Stents 175
10.1.4 Neurological Diagnostic Equipment 175
10.1.4.1 Electroencephelograms (EEG) 175
10.1.4.2 Electromyograms (EMG) 175
10.1.4.3 ICP Monitoring Devices 176
10.1.5 Neurostimulation Devices 176
10.1.5.1 Cortical Stimulator 176
10.1.5.2 Deep Brain Stimulators 176
10.1.5.3 Sacral Nerve Stimulator 176
10.1.5.4 Spinal Cord Stimulators 176
10.1.5.5 Vagus Nerve Stimulators 176
10.1.6 Neurosurgical Products 177
10.1.6.1 Neuroendoscopes 177
10.1.6.2 Neurosurgical Drills 177
10.2 Sources 177
10.3 Acronyms 177
10.4 Research Methodology 178
10.4.1 Secondary Research 179
10.4.2 Primary Research 179
10.4.3 Modeling and Forecasting 180
10.5 Contact Us 180
10.6 Disclaimer 180

List of Figures
Figure 1: Neurology Devices Market, Global, Overall Revenues ($bn), 2010–2017 13
Figure 2: Neurology Devices Market, Global, Company Share (%), 2010 15
Figure 3: Neurology Devices Market, Global ,Geographic Contribution (%), 2010 16
Figure 4: Neurology Devices Market, Global, Revenue ($m), 2003–2010 20
Figure 5: Neurology Devices Market, Global, Revenue ($m), 2010–2017 22
Figure 6: Neurology Devices Market Dynamics 27
Figure 7: Neurology Device Market, Global, Company Share (%), 2010 32
Figure 8: Neurology Devices Market Categorization and Segmentation 34
Figure 9: CSF Management Market, Global, Revenue ($m), 2003–2010 36
Figure 10: CSF Management Market, Global, Revenue ($m), 2010–2017 37
Figure 11: CSF Management, Market Dynamics 39
Figure 12: CSF Management Market, Global, Company Share (%), 2010 42
Figure 13: Neurosurgical Products Market, Global, Revenue ($m), 2003–2010 44
Figure 14: Neurosurgical Products Market, Global, Revenue ($m), 2010–2017 46
Figure 15: Neurosurgical Products Market Dynamics 47
Figure 16: Neurosurgical Products Market, Global, Company Share (%), 2010 50
Figure 17: Neurostimulation Devices Market, Global, Revenue ($m), 2003–2010 52
Figure 18: Neurostimulation Devices Market, Global, Revenue ($m), 2010–2017 54
Figure 19: Neurostimulation Devices Market Dynamics 55
Figure 20: Potential of Neurostimulation Devices for the Treatment of Various Indications, 2010 56
Figure 21: Neurology Devices, Global, Number of Pipeline Products, 2011 58
Figure 22: Neurostimulation Devices Market, Global, Company Shares (%), 2010 63
Figure 23: Interventional Neurology Market, Global, Revenue ($m), 2003–2010 66
Figure 24: Interventional Neurology Market, Global, Revenue ($m), 2010–2017 68
Figure 25: Interventional Neurology, Market Dynamics 70
Figure 26: Interventional Neurology Market, Global, Company Shares (%), 2010 72
Figure 27: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2003–2010 74
Figure 28: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2010–2017 76
Figure 29: Neurological Diagnostic Equipment, Market Dynamics 77
Figure 30: Neurological Diagnostic Equipment Market, Global, Company Shares (%), 2010 81
Figure 31: Neurology Devices Market, Cross Country Analysis, Global, CAGR (%), 2003–2017 83
Figure 32: Neurology Devices Market, US, Revenue ($m), 2003–2010 85
Figure 33: Neurology Devices Market, US, Revenue ($m), 2010–2017 87
Figure 34: Neurology Devices Market, Canada, Revenue ($m), 2003–2010 89
Figure 35: Neurology Devices Market, Canada, Revenue ($m), 2010–2017 91
Figure 36: Neurology Devices Market, UK, Revenue ($m), 2003–2010 93
Figure 37: Neurology Devices Market, UK, Revenue ($m), 2010–2017 94
Figure 38: Neurology Devices Market, Germany, Revenue ($m), 2003–2010 96
Figure 39: Neurology Devices Market, Germany, Revenue ($m), 2010–2017 98
Figure 40: Neurology Devices Market, France, Revenue ($m), 2003–2010 100
Figure 41: Neurology Devices Market, France, Revenue ($m), 2010–2017 101
Figure 42: Neurology Devices Market, Italy, Revenue ($m), 2003–2010 103
Figure 43: Neurology Devices Market, Italy, Revenue ($m), 2010–2017 105
Figure 44: Neurology Devices Market, Spain, Revenue ($m), 2003–2010 106
Figure 45: Neurology Devices Market, Spain, Revenue ($m), 2010–2017 108
Figure 46: Neurology Devices Market, Japan, Revenue ($m), 2003–2010 110
Figure 47: Neurology Devices Market, Japan, Revenue ($m), 2010–2017 112
Figure 48: Neurology Devices Market, China, Revenue ($m), 2003–2010 114
Figure 49: Neurology Devices Market, China, Revenue ($m), 2010–2017 115
Figure 50: Neurology Devices Market, India, Revenue ($m), 2003–2010 117
Figure 51: Neurology Devices Market, India, Revenue ($m), 2010–2017 118
Figure 52: Neurology Devices Market, Australia, Revenue ($m), 2003–2010 120
Figure 53: Neurology Devices Market, Australia, Revenue ($m), 2010–2017 121
Figure 54: Neurology Devices Market, Brazil, Revenue ($m), 2003–2010 123
Figure 55: Neurology Devices Market, Brazil, Revenue ($m), 2010–2017 124
Figure 56: Neurology Devices Market Opportunities and Risk Evaluation, Global, by Segment 126
Figure 57: Neurology Devices, Competitive Assessment, 2011 129
Figure 58: Medtronic, Inc, SWOT Analysis, Neurology Devices, Global, 2010 132
Figure 59:Boston Scientific Corporation, SWOT Analysis, Neurology Devices, Global, 2010 135
Figure 60: St. Jude Medical, Inc, SWOT Analysis, Neurology Devices, Global, 2010 137
Figure 61: Integra LifeSciences Holdings Corporation, SWOT Analysis, Neurology Devices, Global, 2010 141
Figure 62: B. Braun Melsungen AG, SWOT Analysis, Neurology Devices, Global, 2010 143
Figure 63: Cadwell Laboratories, Inc, SWOT Analysis, Neurology Devices, Global, 2010 146
Figure 64: Neurology Devices: Pipeline Products Summary, 2011 147
Figure 65: Neurology Device Market, Mergers & Acquisitions, by Volume, Global, 2007-2010 167

List of Tables
Table 1: Neurology Devices Market, Global, Revenue ($m), 2003–2010 21
Table 2: Neurology Devices Market, Global, Revenue ($m), 2010–2017 23
Table 3: Neurology Device Market, Global, Key Company Revenues ($m), 2010 33
Table 4: CSF Management Market, Global, Revenue ($m), 2003–2010 36
Table 5: CSF Management Market, Global, Revenue ($m), 2010–2017 38
Table 6: CSF Management Market, Global, Key Company Revenues ($m), 2010 43
Table 7: Neurosurgical Products Market, Global, Revenue ($m), 2003–2010 45
Table 8: Neurosurgical Products Market, Global, Revenue ($m), 2010–2017 46
Table 9: Neurosurgical Products Market, Global, Key Company Revenues ($m), 2010 50
Table 10: Neurostimulation Devices Market, Global, Revenue ($m), 2003–2010 53
Table 11: Neurostimulation Devices Market, Global, Revenue ($m), 2010–2017 54
Table 12: Neurostimulation Devices Market, Global, Key Company Revenues ($m), 2010 64
Table 13: Interventional Neurology Market, Global, Revenue ($m), 2003–2010 67
Table 14: Interventional Neurology Market, Global, Revenue ($m), 2010–2017 69
Table 15: Interventional Neurology Market, Global, Key Company Revenues ($m), 2010 73
Table 16: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2003–2010 75
Table 17: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2010–2017 76
Table 18: Neurological Diagnostic Equipment Market, Global, Key Company Revenues ($m), 2010 82
Table 19: Neurology Devices Market, Cross Country Analysis, Global, CAGR (%), 2003–2017 84
Table 20: Neurology Devices Market, US, Revenue ($m), 2003–2010 86
Table 21: Neurology Devices Market, US, Revenue ($m), 2010–2017 88
Table 22: Neurology Devices Market, Canada, Revenue ($m), 2003–2010 90
Table 23: Neurology Devices Market, Canada, Revenue ($m), 2010–2017 92
Table 24: Neurology Devices Market, UK, Revenue ($m), 2003–2010 93
Table 25: Neurology Devices Market, UK, Revenue ($m), 2010–2017 95
Table 26: Neurology Devices Market, Germany, Revenue ($m), 2003–2010 97
Table 27: Neurology Devices Market, Germany, Revenue ($m), 2010–2017 99
Table 28: Neurology Devices Market, France, Revenue ($m), 2003–2010 100
Table 29: Neurology Devices Market, France, Revenue ($m), 2010–2017 102
Table 30: Neurology Devices Market, Italy, Revenue ($m), 2003–2010 104
Table 31: Neurology Devices Market, Italy, Revenue ($m), 2010–2017 105
Table 32: Neurology Devices Market, Spain, Revenue ($m), 2003–2010 107
Table 33: Neurology Devices Market, Spain, Revenue ($m), 2010–2017 109
Table 34: Neurology Devices Market, Japan, Revenue ($m), 2003–2010 111
Table 35: Neurology Devices Market, Japan, Revenue ($m), 2010–2017 112
Table 36: Neurology Devices Market, China, Revenue ($m), 2003–2010 114
Table 37: Neurology Devices Market, China, Revenue ($m), 2010–2017 116
Table 38: Neurology Devices Market, India, Revenue ($m), 2003–2010 117
Table 39: Neurology Devices Market, India, Revenue ($m), 2010–2017 119
Table 40: Neurology Devices Market, Australia, Revenue ($m), 2003–2010 120
Table 41: Neurology Devices Market, Australia, Revenue ($m), 2010–2017 122
Table 42: Neurology Devices Market, Brazil, Revenue ($m), 2003–2010 123
Table 43: Neurology Devices Market, Brazil, Revenue ($m), 2010–2017 125
Table 44: Neurology Devices: Pipeline Products Summary, 2011 148
Table 45: Neurostimulation Devices: List of Pipeline Products-1, 2011 149
Table 45: Neurostimulation Devices: List of Pipeline Products-2, 2011 150
Table 45: Neurostimulation Devices: List of Pipeline Products-3, 2011 151
Table 45: Neurostimulation Devices: List of Pipeline Products-4, 2011 152
Table 49: Neurostimulation Devices: List of Pipeline Products, 5, 2011 153
Table 50: Interventional Neurology: List of Pipeline Products, 1, 2011 157
Table 51: Interventional Neurology: List of Pipeline Products, 1, 2011 158
Table 52: Neurological Diagnostic Equipment: List of Pipeline Products, 1, 2011 161
Table 53: Neurological Diagnostic Equipment: List of Pipeline Products, 2, 2011 162
Table 54: Neurosurgical Products: List of Pipeline Products, 2011 164
Table 55: CSF Management: List of Pipeline Products, 2011 165
Table 56: Neurology Device Market, Mergers & Acquisitions, by Volume Global, 2007-2010 167
Table 57: Neurology Device Market, Mergers & Acquisitions, by Volume, Global, 2007-2010 169
Table 58: Neurology Device Market, Mergers & Acquisitions, by Volume, Global, 2007-2010 170

Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 219261, price: INR 211833, GBI Research

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online